VivoSeq
Other

Frozen Embryo Transfer

0

Pipeline Programs

8

Active Trials

1

Companies Involved

Frozen Embryo Transfer is an early-stage landscape with 0 programs across 1 company. The most active players are Freya Biosciences ApS.

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

3/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

39

clinical trials

Completed17 · 44%
Unknown status12 · 31%
Recruiting5 · 13%
Not yet recruiting2 · 5%
Suspended1 · 3%
Active, not recruiting1 · 3%
Other1 · 3%

Trial Activity

39 trials

Effect of HCG on Endometrial Preparation in Frozen Embryo Transfer
Active, not recruiting··N/A·NCT06577181·50 enrolled
Comparison of Two Protocols in Frozen Embryo Transfer
Not yet recruiting··N/A·NCT07003373·112 enrolled
Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation
Completed··Phase 4·NCT01943812·287 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)